
Reinforced Ventures
Description
Reinforced Ventures is a Pittsburgh, Pennsylvania-based venture capital firm established in 2023 by brothers Michael G. DeRosa and Peter G. DeRosa. The firm distinguishes itself by focusing on "overlooked areas" within the deep tech landscape, aiming to identify and support companies that are building at the intersection of profound scientific discovery and advanced engineering. Their investment philosophy is rooted in the belief that the next generation of transformative innovation will emerge from founders possessing irreplaceable domain expertise who are tackling some of the world's most complex challenges.
The firm's investment mandate spans a diverse range of cutting-edge sectors, including robotics, artificial intelligence, biotechnology, advanced materials, quantum computing, and space technology. Reinforced Ventures specifically seeks out companies developing truly disruptive technologies with the potential to either forge entirely new markets or significantly reshape existing ones. They are particularly interested in ventures that leverage groundbreaking advancements to create foundational solutions in hard-tech domains.
Reinforced Ventures primarily targets Seed-stage companies, providing crucial early-stage capital to promising ventures. Their typical initial check size ranges from $250,000 to $1,000,000, indicating a commitment to supporting nascent deep tech startups as they develop their core technologies and initial market strategies. As a relatively new entrant to the VC ecosystem, having been founded in 2023, the firm is actively building its portfolio, with early investments reflecting its focus on areas like biotech and drug discovery. Reinforced Ventures aims to be more than just a capital provider, seeking to partner with founders who are poised to drive significant technological and societal impact.
Investor Profile
Reinforced Ventures has backed more than 45 startups, with 1 new investments in the last 12 months alone. The firm has led 3 rounds, about 7% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Pre Seed, Series A rounds (top funding stages).
- Majority of deals are located in United States, Israel, Canada.
- Strong thematic focus on Biotechnology, Robotics, Health Care.
- Typical check size: $250K – $1M.
Stage Focus
- Seed (64%)
- Pre Seed (27%)
- Series A (7%)
- Series B (2%)
Country Focus
- United States (87%)
- Israel (7%)
- Canada (7%)
Industry Focus
- Biotechnology
- Robotics
- Health Care
- Machine Learning
- Artificial Intelligence (Ai)
- Therapeutics
- Software
- Information Technology
- Food And Beverage
- Life Science
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.